Alterations of erythrocyte morphology and lipid composition by hyperbilirubinemia

Clinica Chimica Acta

Volumn 249, Issue 1-2, 1996, Pages 149-165

  Brito, Maria A ^a   Silva, Rui M ^a   Matos, Deolinda C ^b   Da Silva, António T ^b   Brites, Dora T ^a  

^a UNIVERSITY OF LISBON   (Portugal)

^b HOSPITAL GARCIA DE ORTA   (Portugal)

Author keywords

Bilirubin toxicity; Erythrocyte membrane lipids; Erythrocyte morphology; Neonates

Indexed keywords

BILIRUBIN; CHOLESTEROL; LIPID; PHOSPHOLIPID;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ERYTHROCYTE GHOST; ERYTHROCYTE MEMBRANE; HEMOLYSIS; HUMAN; HUMAN CELL; HYPERBILIRUBINEMIA; JAUNDICE; LIPID COMPOSITION; MEMBRANE VESICLE; NEWBORN; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL;

EID: 0029970123     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-8981(96)06285-7     Document Type: Article

References (55)

1. Burton EM, Babcock DS, Heubi JE, Gelfand MJ. Neonatal jaundice: clinical and ultrasonographic findings. South Med J 1990;83:294-302.
2. Seidman DS, Paz I, Stevenson DK, Laor A, Danon YL, Gale R. Neonatal hyperbilirubinemia and physical cognitive performance at 17 years of age. Pediatrics 1991;88:828-833.
3. Brown LP. Breastfeeding and jaundice: cause for concern? NAACOGS Clin Issues Perinatal Women's Health Nurs 1992;3:613-619.
4. Penn AA, Enzmann DR, Hahn JS. Kernicterus in a full term infant. Pediatrics 1994;93:1003-1006.
5. Tiribelli C, Ostrow JD. New concepts in bilirubin chemistry, transport and metabolism: report of the second international bilirubin workshop, April 9-11, 1992, Trieste, Italy. Hepatology 1993;17:715-736.
6. Hayer M, Piva M-T, Sieso V, Magnan de Bornier B. Experimental studies on unconjugated bilirubin binding by human erythrocytes. Clin Chim Acta 1989;186:345-350.
7. Ochoa ELM, Wennberg RP, An Y et al. Interactions of bilirubin with isolated presynaptic nerve terminals: functional effects on the uptake and release of neurotransmitters. Cell Mol Neurobiol 1993;13:69-86.
8. Amit Y, Boneh A. Bilirubin inhibits protein kinase C activity and protein kinase C-mediated phosphorylation of endogenous substrates in human skin fibroblasts. Clin Chim Acta 1993;223:103-111.
9. Hansen TWR, Paulsen O, Gjerstad L, Bratlid D. Short-term exposure to bilirubin reduces synaptic activation in rat transverse hippocampal slices. Pediatr Res 1988;23:453-456.
10. Kaul R, Bajpai VK, Shipstone AC, Kaul HK, Krishna Murti CR. Bilirubin-induced erythrocyte membrane cytotoxicity. Exp Mol Pathol 1981;34:290-298.
11. Kirschner-Zilber I, Rabizadeh E, Shaklai N. The interaction of hemin and bilirubin with human red cell membrane. Biochim Biophys Acta 1982;690:20-30.
12. Sato H, Aono S, Semba R, Kashiwamata S. Interaction of bilirubin with human erythrocyte membranes. Bilirubin binding to neuraminidase-and phospholipase-treated membranes. Biochem J 1987;248:21-26.
13. Bratlid D. Bilirubin binding by human erythrocytes. Scand J Clin Lab Invest 1972;29:91-97.
14. Wennberg RP. The importance of free bilirubin acid salt in bilirubin uptake by erythrocytes and mitochondria. Pediatr Res 1988;23:443-447.
15. Sheetz MP, Singer SJ. Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions. Proc Natl Acad Sci USA 1974;71:4457-4461.
16. Lovrien R, Tisel W, Pesheck P. Stoichiometry of compounds bound to human erythrocytes in relation to morphology. J Biol Chem 1975;250:3136-3141.
17. Fujii T, Sato T, Tamura A, Wakatsuki M, Kanaho Y. Shape changes of human erythrocytes induced by various amphipathic drugs acting on the membrane of the intact cells. Biochem Pharmacol 1979;28:613-620.
18. Kanaho Y, Sato T, Fujii T. The affinity of various phenothiazine drugs for membranes of intact human erythrocytes and their membrane-transforming activity. Mol Pharmacol 1981;20:704-708.
19. Ali S, Zakim D. The effects of bilirubin on the thermal properties of phosphatidylcholine bilayers. Biophys J 1993;65:101-105.
20. Vazquez J, Garcia-Calvo M, Valdivieso F, Mayor F, Mayor F Jr. Interaction of bilirubin with synaptosomal plasma membrane. J Biol Chem 1988;263:1255-1265.
21. Amit Y, Cashore W, Schiff D. Studies of bilirubin toxicity at the synaptosome and cellular levels. Semin Perinatal 1992;16:186-190.
22. Mustafa MG, King TE. Binding of bilirubin with lipid. A possible mechanism of its toxic reactions in mitochondria. J Biol Chem 1970;245:1084-1089.
23. Sato H, Kashiwamata S. Interaction of bilirubin with human erythrocyte membranes. Biochem J 1983;210:489-496.
24. Chen LX, Lu JF, Wang K. The influence of bilirubin on fluidity and rotational correlation times of human erythrocyte membrane. Cell Biol Inter Rep 1992;16:567-573.
25. Zucker SD, Goessling W, Zeidel ML, Gollan JL. Membrane lipid composition and vesicle size modulate bilirubin intermembrane transfer. J Biol Chem 1994;269:19262-19270.
26. Brown AK. Erythrocyte metabolism and hemolysis in the newborn. Pediatr Clin N Am 1966;13:879-903.
27. Stockman JA, Oski FA. Erythrocytes of the human neonate. Curr Topics Hematol 1978;1:193-232.
28. Matovcik LM, Mentzer WC. The membrane of the human neonatal red cell. Clin Haematol 1985;14:203-221.
29. Jain SK. The neonatal erythrocyte and its oxidative susceptibility. Semin Hematol 1989;26:286-300.
30. Linderkamp O, Friederichs E, Meiselman HJ. Mechanical and geometrical properties of density-separated neonatal and adult erythrocytes. Pediatr Res 1993;34:688-693.
31. Christensen T, Kinn G. Bilirubin bound to cells does not form photoisomers. Acta Paediatr 1993;82:22-25.
32. Brodersen R. Physical chemistry of bilirubin: binding to macromolecules and membranes. In: Heirwegh KPM, Brown SB, eds. Bilirubin. Chemistry Vol I. Boca Raton: CRC Press, 1982;75-124.
33. Hsu RC, Kanofsky JR, Yachnin S. The formation of echinocytes by the insertion of oxygenated sterol compounds into red cell membranes. Blood 1980;56:109-117.
34. Dodge JT, Mitchell C, Hanahan DJ. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys 1963; 100:119-129.
35. Rose HG, Oklander M. Improved procedure for the extraction of lipids from human erythrocytes. J Lip Res 1965;6:428-431.
36. Rouser G, Fleischer S, Yamamoto A. Two dimensional thin layer Chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 1969;5:494-496.
37. Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem 1959;234:466-468.
38. Ott P, Binggeli Y, Brodbeck URS. A rapid and sensitive assay for determination of cholesterol in membrane lipid extracts. Biochim Biophys Acta 1982;685:211-213.
39. Jendrassik L, Grof P. Vereinfachte photometrische methoden zur bestimmung des blutbilirubins. Biochem Z 1938;297:81-89.
40. Pays M, Beljean M. Microdetermination of unbound bilirubin in sera. Application to the prevention of kernicterus by estimating the bilirubin-binding capacity of serum albumin. Clin Chim Acta 1975;59:121-128.
41. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurements with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
42. Braga A, Brites D, Poeiras J. Avaliação da hemoglobina como contaminante de preparaêções de membranas eritrocitárias. Adaptac̃ão do método de Marklund. Arq Port Cinc Biol 1987;21:115-129.
43. Petrich C, Krieg W, Voss Hv, Göbel U. Effects of bilirubin on red cell metabolism. J Clin Chem Clin Biochem 1977;15:77-80.
44. Chen JY, Ling UP. Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility. Chung Hua I Hsueh Tsa Chih Taipei 1994;53:13-18.
45. Valaes T. Bilirubin toxicity: the problem was solved a generation ago. Pediatrics 1992,89:819-821.
46. Wennberg RP. Bilirubin recommendations present problems: new guidelines simplistic and untested. Pediatrics 1992;89:821-822.
47. Merenstein GB. "New" bilirubin recommendations questioned. Pediatrics 1992; 89:822-823.
48. Brown AK, Seidman DS, Stevenson DK. Jaundice in healthy, term neonates: do we need new action levels or new approaches? Pediatrics 1992;89:827-829.
49. Odell GB. Toxicity of bilirubin and assessment of its risk during neonatal life. In: Oliver TK, ed. Neonatal hyperbilirubinemia. New York: Grune and Straton 1980;83-113.
50. Nakamura H. Assessing the risk of kernicterus. Indian J Pediatr 1987;54:625-631.
51. Ostrow JD. Overview of bile pigment metabolism. In: Ostrow JD, ed. Bile pigments and jaundice: molecular, metabolic and medical aspects. New York: Marcel Dekker, 1986;1-6.
52. Perlman M, Frank JW. Bilirubin beyond the blood-brain barrier. Pediatrics 1988;81:304-315.
53. Ogiso T, Iwaki M, Kimori M, Tsukawak C. Erythrocyte membrane penetration of basic drugs and relationship between drug penetration and hemolysis. Chem Pharm Bull 1986;34:4301-4307.
54. Noy N, Leonard M, Zakim D. The kinetics of interactions of bilirubin with lipid bilayers and with serum albumin. Biophys Chem 1992;42:177-188.
55. Zakim D, Wong PTT. A high-pressure, infrared spectroscopic study of the solvation of bilirubin in lipid bilayers. Biochemistry 1990;29:2003-2007.